BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 17575804)

  • 1. Microdetermination of fatty acids by gas chromatography and cardiovascular risk stratification by the "EPA+DHA level".
    Rupp H; Rupp TP; Wagner D; Alter P; Maisch B
    Herz; 2006 Dec; 31 Suppl 3():30-49. PubMed ID: 17575804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
    Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
    Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia.
    Rupp H
    Adv Ther; 2009 Jul; 26(7):675-90. PubMed ID: 19629408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease prevention and treatment.
    von Schacky C
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):193-8. PubMed ID: 19520557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 fatty acids and cardiovascular disease.
    von Schacky C
    Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):129-35. PubMed ID: 17284999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.
    Holub BJ
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):199-204. PubMed ID: 19545988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
    Pauwels EK; Kostkiewicz M
    Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary sesamin and docosahexaenoic and eicosapentaenoic acids synergistically increase the gene expression of enzymes involved in hepatic peroxisomal fatty acid oxidation in rats.
    Arachchige PG; Takahashi Y; Ide T
    Metabolism; 2006 Mar; 55(3):381-90. PubMed ID: 16483883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of very long-chain n-3 fatty acids on plasma markers of inflammation in middle-aged men.
    Yusof HM; Miles EA; Calder P
    Prostaglandins Leukot Essent Fatty Acids; 2008 Mar; 78(3):219-28. PubMed ID: 18403189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.
    Goyens PL; Mensink RP
    Eur J Clin Nutr; 2006 Aug; 60(8):978-84. PubMed ID: 16482073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis.
    Friedman AN; Moe SM; Perkins SM; Li Y; Watkins BA
    Am J Kidney Dis; 2006 Jun; 47(6):1064-71. PubMed ID: 16731302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is body size a biomarker for optimizing dosing of omega-3 polyunsaturated fatty acids in the treatment of patients with IgA nephropathy?
    Donadio JV; Bergstralh EJ; Bibus DM; Grande JP
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):933-9. PubMed ID: 17699310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous quantification of total eicosapentaenoic acid, docosahexaenoic acid and arachidonic acid in plasma by high-performance liquid chromatography-tandem mass spectrometry.
    Salm P; Taylor PJ; Kostner K
    Biomed Chromatogr; 2011 Jun; 25(6):652-9. PubMed ID: 20737653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative bioavailability of eicosapentaenoic acid and docasahexaenoic acid from triglycerides, free fatty acids and ethyl esters in volunteers].
    Beckermann B; Beneke M; Seitz I
    Arzneimittelforschung; 1990 Jun; 40(6):700-4. PubMed ID: 2144420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing EPA+DHA levels in red blood cells in Japan.
    Itomura M; Fujioka S; Hamazaki K; Kobayashi K; Nagasawa T; Sawazaki S; Kirihara Y; Hamazaki T
    In Vivo; 2008; 22(1):131-5. PubMed ID: 18396795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
    Saifullah A; Watkins BA; Saha C; Li Y; Moe SM; Friedman AN
    Nephrol Dial Transplant; 2007 Dec; 22(12):3561-7. PubMed ID: 17623719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients.
    Harris WS; Reid KJ; Sands SA; Spertus JA
    Am J Cardiol; 2007 Jan; 99(2):154-8. PubMed ID: 17223410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation.
    Harris WS; Sands SA; Windsor SL; Ali HA; Stevens TL; Magalski A; Porter CB; Borkon AM
    Circulation; 2004 Sep; 110(12):1645-9. PubMed ID: 15353491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 fatty acids from fish oils and cardiovascular disease.
    Holub DJ; Holub BJ
    Mol Cell Biochem; 2004 Aug; 263(1-2):217-25. PubMed ID: 15524182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular benefits of omega-3 fatty acids.
    von Schacky C; Harris WS
    Cardiovasc Res; 2007 Jan; 73(2):310-5. PubMed ID: 16979604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.